Cargando…

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial

BACKGROUND: Neo-adjuvant chemotherapy followed by radical cystectomy with extended pelvic lymph node dissection is considered to be the treatment of choice for patients with muscle invasive bladder cancer (MIBC). Despite this aggressive treatment the outcome is poor and ultimately, 30% of the patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fonteyne, Valérie, Dirix, Piet, Junius, Sara, Rammant, Elke, Ost, Piet, De Meerleer, Gert, Swimberghe, Martijn, Decaestecker, Karel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414216/ https://www.ncbi.nlm.nih.gov/pubmed/28464906 http://dx.doi.org/10.1186/s12885-017-3302-9

Ejemplares similares

Selecting candidates for early discharge after radical cystectomy for bladder cancer
por: Fonteyne, Valérie, et al.
Publicado: (2018)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial
por: Decaestecker, Karel, et al.
Publicado: (2014)

Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer: a systematic review protocol
por: Rammant, Elke, et al.
Publicado: (2017)

Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial
por: Draulans, Cédric, et al.
Publicado: (2018)

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial
por: Verghote, Flor, et al.
Publicado: (2021)

Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer
por: Fonteyne, Valérie, et al.
Publicado: (2012)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

The Role of Androgen Receptor Expression in the Curative Treatment of Prostate Cancer with Radiotherapy: A Pilot Study
por: Poelaert, Filip, et al.
Publicado: (2015)

Salvage Pelvic Lymph Node Dissection in Recurrent Prostate Cancer: Surgical and Early Oncological Outcome
por: Claeys, Tom, et al.
Publicado: (2015)

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response
por: Sundahl, Nora, et al.
Publicado: (2017)

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial
por: De Wolf, Katrien, et al.
Publicado: (2017)

A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer
por: De Bleser, Elise, et al.
Publicado: (2020)

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
por: Mercier, Carole, et al.
Publicado: (2019)

Pattern of Failure in Bladder Cancer Patients Treated with Radical Cystectomy: Rationale for Adjuvant Radiotherapy
por: Kim, Yong Bae, et al.
Publicado: (2010)

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
por: De Wolf, Katrien, et al.
Publicado: (2015)

Perspective on cytoreduction and metastasis-directed therapy in node positive and metastatic urothelial carcinoma of the bladder
por: Decaestecker, Karel, et al.
Publicado: (2017)

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study
por: Orré, Mathieu, et al.
Publicado: (2017)

Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients
por: Huysse, Wouter, et al.
Publicado: (2017)

Robot assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): study protocol of a non-randomized comparative effectiveness study
por: Wijburg, C. J., et al.
Publicado: (2018)

Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients
por: EL-SAGHIRE, HOUSSEIN, et al.
Publicado: (2014)

The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
por: Lumen, Nicolaas, et al.
Publicado: (2021)

Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer
por: Fischer‐Valuck, Benjamin W., et al.
Publicado: (2019)

Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer
por: Porreca, Angelo, et al.
Publicado: (2021)

Review of the evidence for robotic-assisted robotic cystectomy and intra-corporeal urinary diversion in bladder cancer
por: Brodie, Andrew, et al.
Publicado: (2020)

Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer
por: Pak, Sahyun, et al.
Publicado: (2019)

A Prospective, Observational, Multicentre Study Concerning Nontechnical Skills in Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy
por: Beulens, Alexander J.W., et al.
Publicado: (2020)

A geometry and dose-volume based performance monitoring of artificial intelligence models in radiotherapy treatment planning for prostate cancer
por: De Kerf, Geert, et al.
Publicado: (2023)

Extent of lymphadenectomy in radical cystectomy for bladder cancer
por: Ather, M Hammad, et al.
Publicado: (2005)

Editorial: Radical cystectomy in bladder cancer patients
por: Koshkin, Vadim S., et al.
Publicado: (2022)

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial
por: Spaas, Mathieu, et al.
Publicado: (2021)

Cost-Effectiveness of Robot-Assisted Radical Cystectomy vs Open Radical Cystectomy for Patients With Bladder Cancer
por: Dixon, Simon, et al.
Publicado: (2023)

Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study
por: Fonteyne, Valérie, et al.
Publicado: (2023)

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response
por: De Wolf, Katrien, et al.
Publicado: (2017)

Robot-assisted laparoscopic radical cystectomy with intracorporeal ileal conduit diversion versus open radical cystectomy with ileal conduit for bladder cancer in an ERAS setup (BORARC): protocol for a single-centre, double-blinded, randomised feasibility study
por: Maibom, Sophia Liff, et al.
Publicado: (2023)

Radical Cystectomy and Orthotopic Bladder Substitution Using Ileum
por: Park, Jinsung, et al.
Publicado: (2011)

Patterns of recurrence of bladder carcinoma following radical cystectomy
por: Koh, D. M., et al.
Publicado: (2015)

Immediate Radical Cystectomy for Massive Bleeding of Bladder Cancer
por: Cochetti, Giovanni, et al.
Publicado: (2015)

Robot-Assisted Radical Cystectomy in the Management of Bladder Cancer
por: Keim, Jessica L., et al.
Publicado: (2006)

Robot-assisted laparoscopic radical cystectomy: initial experience on 27 consecutive patients
por: Mottrie, A., et al.
Publicado: (2007)

Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs
por: Morii, Yasuhiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s3stk53bu9gli6v9qgmdhjebul